Impact of adjuvant chemotherapy regimen on survival outcomes in immunohistochemical subtypes of ampullary carcinoma.

Al Abbas, Amr I; Falvello, Virginia; Zenati, Mazen; Mani, Ashika; Hogg, Melissa E; Zeh, Herbert J; Singhi, Aatur; Bahary, Nathan; Zureikat, Amer H

Al Abbas, Amr I; Falvello, Virginia; Zenati, Mazen; Mani, Ashika; Hogg, Melissa E; Zeh, Herbert J; Singhi, Aatur; Bahary, Nathan; Zureikat, Amer H.

Afiliación

Al Abbas AI; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Falvello V; University of Texas Southwestern, Dallas, Texas.
Zenati M; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Mani A; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Hogg ME; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Zeh HJ; Northshore University HealthSystem, Evanston, Illinois.
Singhi A; University of Texas Southwestern, Dallas, Texas.
Bahary N; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Zureikat AH; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

J Surg Oncol ; 121(2): 322-329, 2020 Feb.

Article en En | MEDLINE | ID: mdl-31840257

Palabras clave

adjuvant chemotherapy; ampullary carcinoma; immunohistologic subtype

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Surg Oncol Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google